Introduction

Male breast cancer (MBC) is a rare condition usually diagnosed later and in more advanced stages than female breast cancer.

Material and methods

A 10-year retrospective review of MBC in our hospital.

Results

Our series included 13 cases. We analyzed the form of presentation, way of diagnosis, BRCA mutation, histology of the tumor, the type of treatment and survival.

Discussion

The incidence of MBC is currently increasing. The average age of presentation is 62 years. They usually consult because of a nodule or painless retroareolar tumor. Lymph node involvement is often diagnosed. Diagnosis is usually late, which contributes to the infiltration of the pectoralis major muscle. There is no screening in males. Surgical treatment consists of the removal of the primary tumor. The axillary treatment is based on the selective biopsy of the sentinel ganglion (BSGC) for its staging. The use of radio, chemo and endocrine therapy is usually advised depending on the axillary and distance staging, and the type of hormonal receptors of the tumor. Overall and disease-free survival in males are below the ones in the female population.

Conclusion

Most of the conclusions of this pathology in the male derive from studies of female breast cancer.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )